Stem Cell Therapy in Duchenne Muscular Dystrophy
NCT02241434 · Status: WITHDRAWN · Phase: PHASE1 · Type: INTERVENTIONAL
Last updated 2018-10-25
Summary
The purpose of this study was to study the effect of stem cell therapy in patients with Duchenne Muscular Dystrophy.
Conditions
Interventions
- BIOLOGICAL
-
Stem Cell
Intrathecal autologous bone marrow mononuclear cell transplantation
Sponsors & Collaborators
-
Neurogen Brain and Spine Institute
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 3 Years
- Max Age
- 25 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-01-31
- Primary Completion
- 2016-01-31
- Completion
- 2016-06-30
Countries
- India
Study Locations
More Related Trials
-
Cell Therapy for Motor Neuron Disease/Amyotrophic Lateral Sclerosis
NCT02242071 ·Status: WITHDRAWN ·Phase: PHASE1
-
Stem Cell Therapy for Amyotrophic Lateral Sclerosis
NCT01984814 ·Status: WITHDRAWN ·Phase: PHASE2
-
Bone Marrow-Derived Autologous Stem Cells for the Treatment of Duchenne Muscular Dystrophy
NCT03067831 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Duchenne Muscular Dystrophy
NCT01610440 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Efficacy of Stem Cell Therapy in Ambulatory and Non-ambulatory Children With Duchenne Muscular Dystrophy - Phase 1-2
NCT02484560 ·Status: UNKNOWN ·Phase: PHASE1
-
Clinical Study to Evaluate the Safety and Efficacy BMMNC in Cerebellar Ataxia
NCT01958177 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Strength Training in Duchenne Muscular Dystrophy
NCT02421523 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy Study of PTC124 in Duchenne Muscular Dystrophy
NCT00264888 ·Status: COMPLETED ·Phase: PHASE2
-
Trial of Cell Based Therapy for DMD
NCT06692426 ·Status: RECRUITING ·Phase: PHASE1
-
Research of Biomarkers in Duchenne Muscular Dystrophy Patients
NCT01380964 ·Status: COMPLETED
-
Creatine and Glutamine in Steroid-Naive Duchenne Muscular Dystrophy
NCT00016653 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Mesenchymal Stem Cells for Treatment of Amyotrophic Lateral Sclerosis (ALS)
NCT01142856 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Trial on the Use of Cell Therapy in the Treatment of Patients With Amyotrophic Lateral Sclerosis
NCT04849065 ·Status: UNKNOWN ·Phase: PHASE2
-
Allogeneic Human Umbilical Cord Mesenchymal Stem Cells for a Single Male Patient With Duchenne Muscular Dystrophy (DMD)
NCT02235844 ·Status: COMPLETED ·Phase: PHASE1
-
Expanded Access Study of UC-MSC in DMD Patients
NCT06579352 ·Status: AVAILABLE
-
Efficacy of Umbilical Cord Mesenchymal Stem Cells in Duchenne Muscular Dystrophy
NCT02285673 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Neurologic Stem Cell Treatment Study
NCT02795052 ·Status: RECRUITING ·Phase: NA
-
The Safety, Efficacy and Tolerability of Remote Ischemic Preconditioning as a Therapy to DMD
NCT02614820 ·Status: UNKNOWN ·Phase: NA
-
Compassionate Treatment : An Exploratory Clinical Trial to Assess Treatment of Amyotrophic Lateral Sclerosis
NCT02383654 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluate Umbilical Cord-derived Allogeneic Mesenchymal Stem Cells for the Treatment of Bradykinesia
NCT04385056 ·Status: UNKNOWN ·Phase: PHASE1
-
Exploring the Physiologic, Pharmacodynamic, and Clinical Responses of Skeletal Muscle in Patients With Spinal Muscular Atrophy Treated With SMN-Directed Therapies
NCT06532474 ·Status: RECRUITING
-
Characterization of Clinical Skeletal and Cardiac Impairment in Carriers of DMD and BMD
NCT02972580 ·Status: ACTIVE_NOT_RECRUITING
-
Autologous Bone Marrow Mesenchymal Stem Cells in the Treatment of Patients With Amyotrophic Lateral Sclerosis
NCT02881489 ·Status: UNKNOWN ·Phase: PHASE1
-
A Phase III Double-blind Study With Idebenone in Patients With Duchenne Muscular Dystrophy (DMD) Taking Glucocorticoid Steroids
NCT02814019 ·Status: TERMINATED ·Phase: PHASE3
-
Prognostic Factors Affecting Duchenne Muscular Dystrophy
NCT03372655 ·Status: UNKNOWN